Tower Research Capital (TRC)’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $880K | Buy |
1,661
+830
| +100% | +$383K | 0.02% | 695 |
|
|
2026
Q1 | $399K | Buy |
831
+76
| +10% | +$38.9K | 0.01% | 1087 |
|
|
2025
Q4 | $424K | Sell |
755
-139
| -16% | -$78.9K | 0.01% | 918 |
|
|
2025
Q3 | $460K | Buy |
894
+361
| +68% | +$158K | 0.01% | 921 |
|
|
2025
Q2 | $167K | Buy |
533
+156
| +41% | +$46.8K | ﹤0.01% | 1953 |
|
|
2025
Q1 | $115K | Sell |
377
-2,194
| -85% | -$738K | ﹤0.01% | 1702 |
|
|
2024
Q4 | $854K | Buy |
2,571
+1,314
| +105% | +$446K | 0.02% | 709 |
|
|
2024
Q3 | $420K | Buy |
1,257
+862
| +218% | +$327K | 0.01% | 993 |
|
|
2024
Q2 | $163K | Sell |
395
-1,729
| -81% | -$685K | ﹤0.01% | 2227 |
|
|
2024
Q1 | $858K | Sell |
2,124
-1,769
| -45% | -$622K | 0.02% | 583 |
|
|
2023
Q4 | $1.19M | Buy |
3,893
+1,335
| +52% | +$360K | 0.01% | 753 |
|
|
2023
Q3 | $619K | Buy |
2,558
+916
| +56% | +$234K | 0.02% | 754 |
|
|
2023
Q2 | $394K | Sell |
1,642
-219
| -12% | -$45.5K | 0.01% | 1129 |
|
|
2023
Q1 | $350K | Buy |
1,861
+909
| +95% | +$188K | 0.01% | 1045 |
|
|
2022
Q4 | $203K | Sell |
952
-1,323
| -58% | -$264K | 0.01% | 1298 |
|
|
2022
Q3 | $358K | Buy |
2,275
+291
| +15% | +$46.4K | 0.01% | 1409 |
|
|
2022
Q2 | $297K | Buy |
1,984
+1,161
| +141% | +$168K | 0.01% | 1489 |
|
|
2022
Q1 | $135K | Sell |
823
-2,054
| -71% | -$339K | ﹤0.01% | 2004 |
|
|
2021
Q4 | $626K | Buy |
2,877
+1,113
| +63% | +$233K | 0.01% | 963 |
|
|
2021
Q3 | $334K | Sell |
1,764
-1,882
| -52% | -$343K | 0.01% | 1295 |
|
|
2021
Q2 | $644K | Sell |
3,646
-2,768
| -43% | -$478K | 0.02% | 972 |
|
|
2021
Q1 | $1.05M | Buy |
6,414
+3,458
| +117% | +$529K | 0.02% | 759 |
|
|
2020
Q4 | $411K | Buy |
2,956
+1,470
| +99% | +$185K | 0.01% | 1146 |
|
|
2020
Q3 | $166K | Sell |
1,486
-1,257
| -46% | -$145K | ﹤0.01% | 2741 |
|
|
2020
Q2 | $255K | Buy |
2,743
+2,695
| +5,615% | +$229K | 0.01% | 1587 |
|
|
2020
Q1 | $4K | Buy |
+48
| New | +$4.17K | ﹤0.01% | 2378 |
|
|
2019
Q4 | – | Sell |
-29
| Closed | -$2K | – | 4042 |
|
|
2019
Q3 | $2K | Sell |
29
-1,965
| -99% | -$148K | ﹤0.01% | 3706 |
|
|
2019
Q2 | $130K | Buy |
+1,994
| New | +$115K | 0.01% | 1038 |
|
|
2019
Q1 | – | Sell |
-74
| Closed | -$4K | – | 4083 |
|
|
2018
Q4 | $4K | Buy |
+74
| New | +$4.06K | ﹤0.01% | 3051 |
|
|
2017
Q2 | – | Sell |
-1,715
| Closed | -$51K | – | 3149 |
|
|
2017
Q1 | $51K | Buy |
1,715
+1,488
| +656% | +$48K | 0.01% | 724 |
|
|
2016
Q4 | $9K | Sell |
227
-2,410
| -91% | -$80.3K | ﹤0.01% | 2718 |
|
|
2016
Q3 | $79K | Buy |
+2,637
| New | +$77K | 0.01% | 916 |
|
Other funds holding MEDP
WA
Tower Research Capital (TRC)'s MEDP Position: Q2 2026 in Review
Tower Research Capital (TRC) increased its Medpace (MEDP) stake by 100% in Q2 2026, buying an estimated $383K and bringing the position to 1,661 shares worth $880K. The position accounts for 0.02% of the portfolio, ranked #695.
Tower Research Capital (TRC) first reported a position in MEDP in Q3 2016 and has held it in 32 quarters since. The position peaked at $1.19M in Q4 2023. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- Tower Research Capital (TRC) held 1,661 shares of Medpace worth $880K as of Q2 2026.
- Tower Research Capital (TRC) bought 830 Medpace shares in Q2 2026, an estimated $383K.
- Medpace made up 0.02% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #695 holding.
- Tower Research Capital (TRC) first reported a position in Medpace in Q3 2016 and has held it in 32 quarters since.
- Tower Research Capital (TRC)'s Medpace position peaked at $1.19M in Q4 2023.
- 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.